Free Trial
NASDAQ:TENX

Tenax Therapeutics (TENX) Stock Price, News & Analysis

Tenax Therapeutics logo
$5.96 +0.22 (+3.83%)
As of 07/3/2025 02:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Tenax Therapeutics Stock (NASDAQ:TENX)

Key Stats

Today's Range
$5.80
$5.93
50-Day Range
$5.36
$6.25
52-Week Range
$2.80
$7.89
Volume
5,974 shs
Average Volume
162,159 shs
Market Capitalization
$24.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.50
Consensus Rating
Buy

Company Overview

Tenax Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

TENX MarketRank™: 

Tenax Therapeutics scored higher than 25% of companies evaluated by MarketBeat, and ranked 815th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenax Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tenax Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tenax Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Tenax Therapeutics are expected to decrease in the coming year, from ($0.88) to ($3.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenax Therapeutics is -2.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenax Therapeutics is -2.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tenax Therapeutics has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Tenax Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    8.58% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently increased by 0.29%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Tenax Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Tenax Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.58% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently increased by 0.29%, indicating that investor sentiment is decreasing.
    • Insider Buying vs. Insider Selling

      In the past three months, Tenax Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.14% of the stock of Tenax Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 1.67% of the stock of Tenax Therapeutics is held by institutions.

    • Read more about Tenax Therapeutics' insider trading history.
    Receive TENX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    TENX Stock News Headlines

    TENX Tenax Therapeutics, Inc. - Seeking Alpha
    The day and month stocks are most likely to crash next
    Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history gives him 90% historical confidence that stocks will end 2025 up. However, he also has bad news: the same data also tells him the REAL market crash will likely arrive in 2026.
    Tenax Therapeutics Inc.
    Tenax Therapeutics reports Q4 EPS (18c), consensus (43c)
    See More Headlines

    TENX Stock Analysis - Frequently Asked Questions

    Tenax Therapeutics' stock was trading at $6.19 at the beginning of 2025. Since then, TENX shares have decreased by 3.7% and is now trading at $5.96.

    Tenax Therapeutics, Inc. (NASDAQ:TENX) released its quarterly earnings data on Wednesday, May, 14th. The specialty pharmaceutical company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.48) by $0.20.

    Shares of Tenax Therapeutics reverse split on Wednesday, January 3rd 2024.The 1-80 reverse split was announced on Wednesday, January 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

    Shares of TENX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Tenax Therapeutics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Broadcom (AVGO) and Novo Nordisk A/S (NVO).

    Company Calendar

    Last Earnings
    5/14/2025
    Today
    7/06/2025
    Next Earnings (Estimated)
    8/12/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:TENX
    Employees
    9
    Year Founded
    1967

    Price Target and Rating

    Average Stock Price Target
    $17.50
    High Stock Price Target
    $20.00
    Low Stock Price Target
    $15.00
    Potential Upside/Downside
    +193.6%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.25
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$17.60 million
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $26.99 per share
    Price / Book
    0.22

    Miscellaneous

    Free Float
    4,018,000
    Market Cap
    $24.73 million
    Optionable
    Not Optionable
    Beta
    1.61

    Social Links

    12 Stocks Corporate Insiders are Abandoning Cover

    If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:TENX) was last updated on 7/6/2025 by MarketBeat.com Staff
    From Our Partners